Rufloxacin (Compound)

Synonyms:Rufloxacin, 101363-10-4, MF 934, UNII-Y521XM2900, RUFLOXACIN HCl, C17H18FN3O3S, CHEBI:8909, Y521XM2900, Rufloxacine, Rufloxacino, Rufloxacinum, 7H-Pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-, 8-Fluoro-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-thia-3a-aza-phenalene-5-carboxylic acid, 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid, 9-Fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid;9-Fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid, SMR000466373, Rufloxacine [French], Rufloxacinum [Latin], Rufloxacino [Spanish], Rufloxacin [INN:BAN], SR-01000612324, NCGC00074024-02, Rufloxacin (INN), MLS000759502, MLS001424127, SCHEMBL135502, CHEMBL295619, DTXSID6048412, HMS2051K22, HMS2090N07, HMS3264M18, HMS3393K22, HMS3715P09, Pharmakon1600-01502335, ZINC538328, HY-B0902, RKL10066, BBL008945, NSC759835, STK711124, AKOS004120047, CCG-100908, CS-4367, DB13772, NC00158, NSC 759835, NSC-759835, VA11705, FT-0631011, D02474, AB00474020-18, AB00474020-20, AB00474020_21, 363R104, Q3942356, SR-01000612324-5, SR-01000612324-6, 7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.0^{5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid, 7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid, 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid, 9-Fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid, 9-Fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid

Pubchem:PUBCHEM:58258

Id:58258

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Rufloxacin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Rufloxacin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Rufloxacin.

Results found

Linked to

	Label	Description
	rufloxacin positively regulates MCTP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin negatively regulates MAGEA6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin positively regulates CTSZ Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin positively regulates RCAN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin positively regulates MYO6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin negatively regulates SFRP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin positively regulates AGT Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin negatively regulates GABRP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin positively regulates ZIC1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	rufloxacin positively regulates S100A10 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS